Mesh removal and ventral hernia repair with long-term absorbable mesh in case of mesh infection
Hernia · 14.10.2025 · 29 (1)
DOI: 10.1007/s10029-025-03475-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Hernia, online erschienen am 14.10.2025. Verfasst von Gaëtan-Romain Joliat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral Surgery, Lausanne University Hospital CHUV, University of Lausanne (UNIL), Lausanne, Switzerland. gaetan.joliat@gmail.com. Hauptthemen laut MEDLINE: Surgical Mesh, Hernia, Ventral, Device Removal, Herniorrhaphy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Lausanne.
Abstract (Originalsprache)
Purpose
Mesh infection after ventral hernia repair remains rare, but often necessitates mesh removal. This study evaluated the short- and long-term outcomes of a strategy involving explantation of the infected mesh and insertion of a long-term absorbable mesh in acute (AMI) and chronic mesh infections (CMI).
Methods
A retrospective study was performed in two tertiary centers (01.01.2017–31.12.2024). All consecutive patients with ventral mesh infection who underwent mesh explantation followed by placement of a long-term absorbable poly-4-hydroxybutyrate mesh were included. Primary endpoint was hernia recurrence rate. AMI was defined as mesh infection within 90 postoperative days.
Results
Twenty-nine patients were included: 14 AMI/15 CMI. Meshes were intraperitoneal in 9/14 (64%) AMI and in 13/15 (87%) CMI patients. Twelve (86%) and 13 patients (87%) had a new mesh implanted in the retromuscular space in the AMI and CMI groups, respectively. Four (28%) and 3 patients (21%) needed posterior component separations in the AMI and CMI groups. Median hospital stays were 10 (5–15) and 7 days (5–13) in both groups. Nine patients in each group (64%/60%) developed postoperative complications. Hernia recurrence rates were 3/14 (21%) and 0 in the AMI and CMI groups (mean follow-up 17 months). One mesh had to be explanted in the AMI group (0 in the CMI group).
Conclusions
The presented strategy was associated with high short-term morbidity, but good long-term results, with low mesh explantation and hernia recurrence rates. A longer follow-up and inclusion of more patients is required to assess the risk of hernia recurrence and reinfection with greater hindsight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Visceral Surgery, Lausanne University Hospital CHUV, University of Lausanne (UNIL), Lausanne, Switzerland. gaetan.joliat@gmail.com.
- Department of General Surgery and Surgical Oncology, Centre Hospitalier Universitaire Lyon Sud, 165, chemin du Grand Revoyet, Pierre-Bénite, 69495, France. gaetan.joliat@gmail.com.
- Department of General Surgery and Surgical Oncology, Centre Hospitalier Universitaire Lyon Sud, 165, chemin du Grand Revoyet, Pierre-Bénite, 69495, France.
- Department of Digestive Surgery, Hôpital de Hautepierre, Strasbourg, France.
ORCID-Profile: Gaëtan-Romain Joliat
Förderung
- University of Lausanne
Zitieren
APA
Joliat, G. R., Passot, G., & Romain, B. (2025). Mesh removal and ventral hernia repair with long-term absorbable mesh in case of mesh infection. Hernia, 29(1). https://doi.org/10.1007/s10029-025-03475-9
Vancouver
Joliat GR, Passot G, Romain B. Mesh removal and ventral hernia repair with long-term absorbable mesh in case of mesh infection. Hernia. 2025;29(1). doi:10.1007/s10029-025-03475-9
BibTeX
@article{Joliat2025,
author = {Joliat, Gaëtan-Romain and Passot, Guillaume and Romain, Benoit},
title = {Mesh removal and ventral hernia repair with long-term absorbable mesh in case of mesh infection},
journal = {Hernia},
year = {2025},
volume = {29},
number = {1},
doi = {10.1007/s10029-025-03475-9}
}
EUVIMED